Cholesterol drug takes aim at cancer protein in early trial
Knowledge-focused
Ongoing
This early-phase study tests whether atorvastatin, a widely used cholesterol medication, can reduce levels of a faulty protein called p53 in people with various cancers, including solid tumors and relapsed acute myeloid leukemia. About 50 participants will take atorvastatin for 1…
Phase: PHASE1 • Sponsor: Joaquina Baranda • Aim: Knowledge-focused
Last updated May 08, 2026 12:00 UTC